Role of polypeptide growth factors in normal and abnormal growth.
In the preceding sections we have shown evidence that growth-promoting factors are involved in three basic situations. In normal embryonic development and function of mature organisms, growth factors such as NGF and EGF are of prime importance in supporting the necessary embryonic cell proliferation and the development of specific cell types. Other factors operate on subsets of mature cells during specialized functions such as inflammation. Included in this set would be factors such as CSF/MGF and Interleukin-2. Another basic function of growth factors has been shown to be wound repair and organ regeneration. This includes the well characterized PDGF and FGF as well as the various renotropic factors and liver growth factors. As these factors must operate in mature organisms with many different cell types and similar cell types in many locations, more specificity is needed than in embryonic growth. This has resulted in the organ specific factors such as the renotropins and in the unique delivery system of the PDGF. The recent discovery and characterization of the transforming growth factors has provided a possible connection between embryonic and normal developmental growth and the rapid cellular proliferation characteristic of tumor cells. The TGF not only interacts with receptors for normal growth factors such as EGF but are also detectable in low levels in normal tissue and embryos. The exact relationships between these various factors will have to await the determinations of more amino acid sequences for comparisons. The other tumor-related product, tumor angiogenesis factor, is also found in normal tissue and inflammatory reaction sites.(ABSTRACT TRUNCATED AT 250 WORDS)
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology; D000818:Animals; D002455:Cell Division; D002471:Cell Transformation, Neoplastic; D004815:Epidermal Growth Factor / Q000502:physiology; D005346:Fibroblast Growth Factors / Q000502:physiology; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D006984:Hypertrophy; D007376:Interleukin-2 / Q000502:physiology; D007377:Interleukin-3 / Q000502:physiology; D009369:Neoplasms / Q000503:physiopathology; D009414:Nerve Growth Factors / Q000502:physiology; D010455:Peptides / Q000494:pharmacology; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D015291:Transforming Growth Factors; D014945:Wound Healing
D043925:Angiogenesis Inducing Agents; D006133:Growth Substances; D007376:Interleukin-2; D007377:Interleukin-3; D009414:Nerve Growth Factors; D010455:Peptides; D010982:Platelet-Derived Growth Factor; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor; D015291:Transforming Growth Factors